Disogenin
CAS 512-04-9
Disogenin (CAS 512-04-9) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 29260.959411764707 nM | 33 | - |
| - | IC50 | 36.36363636363637 ug.mL-1 | 11 | - |
| - | GI50 | 2.37 ug.mL-1 | 6 | - |
| - | MIC | 144 ug.mL-1 | 2 | - |
| - | EC50 | 3800 nM | 1 | - |
| - | Ki | 100000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Disogenin used for in pharmaceutical contexts?
Disogenin (CAS 512-04-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Disogenin?
No adverse-event association or SIDER side-effect rows are rendered for Disogenin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Disogenin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Diosgenin with EU status "permitted".
What clinical phase is Disogenin in?
No phase 1-4 clinical development badge is rendered for Disogenin because the matched compound identifier rows do not contain a max-phase value.